Nexium

Nexium Uses, Dosage, Side Effects, Food Interaction and all others data.

Nexium is under investigation in clinical trial NCT03416491 (Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C).

Trade Name	Nexium
Generic	Coblopasvir
Coblopasvir Other Names	Coblopasvir
Weight	20mg, 40mg, , 49.3mg, 10mg, 2.5mg, 5mg
Type	Tablet, Coated, Powder, For Solution, Oral Delayed Release Capsule, Oral Delayed Release Tablet, Oral Powder For Reconstitution, Delayed Release, Oral, Capsule, Granule, Injection, Powder For Injection
Formula	C₄₁H₅₀N₈O₈
Weight	Average: 782.899 Monoisotopic: 782.375160602
Groups	Investigational
Therapeutic Class
Manufacturer	Astrazeneca Uk Limited, Astrazeneca, Astra Zeneca
Available Country	United Kingdom, Canada, Australia, Saudi Arabia, United States, Netherlands, Portugal, Switzerland, Indonesia, Sweden, Nigeria,
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here Nexium